Antidepressant-Like Effects of Magnolol from Magnolia officinalis in the Forced Swimming Test

Natural Medicines

Volumn 57, Issue 6, 2003, Pages 221-226

  Nakazawa, Takahiro ^a   Yasuda, Takaaki ^a   Ohsawa, Keisuke ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Forced swimming; Magnolia officinalis; Magnolol; Monoamine turnover

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; BRAIN MONOAMINE; DOPAMINE; HALOPERIDOL; MAGNOLIA OFFICINALIS EXTRACT; MAGNOLOL; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC ACTIVITY; DRUG ACTIVITY; DRUG COMPETITION; FORCED SWIMMING TEST; FRONTAL CORTEX; HYPOTHALAMUS; IMMOBILIZATION; MAGNOLIA OFFICINALIS; MAGNOLIACEAE; MALE; MENTAL STRESS; MESENCEPHALON; MONOAMINE METABOLISM; MOUSE; NONHUMAN; SEROTONIN METABOLISM; THALAMUS;

EID: 0442278080     PISSN: 13403443     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Narita, H., Seishinshinkeiyakuri, 12, 165-172 (1990).
2. Yahara, S., Nishiyori, T., Kohda, A., Nohara, T., Nishioka, I., Chem. Pharm. Bull., 39, 2024-2036 (1991).
3. Fujita, M., Itokawa, H., Sashida, Y., YAKUGAKU ZASSHI, 93, 415-421 (1973).
4. Ito, K., Yoshida, A., YAKUGAKU ZASSHI, 86, 124-126 (1966).
5. Hasegawa, T., Fukuyama, Y., Yamada, T., Nakagawa, K., Chem. Pharm. Bull., 36, 1245-1248 (1988).
6. Luo, L., Nong, W. J., Kong, L. D., Jiang, Q. G., Tan, R. X., J. Ethnopharmacol., 73, 277-281 (2000).
7. Porsolt, R. D., Brochet, D., Simon, P., Arch. Int. Pharmacodyn. Ther., 229, 327-336 (1977).
8. Nose, M., Ito, M., Kamimura, K., Shimizu, M., Ogihara, Y., Planta Med., 60, 136-139 (1994).
9. Abdel-Hafez, A. A., Meselhy, M. R., Nakamura, N., Hattori, M., Watanabe, H., Mohamed, T. A., Mahfouz, N. M., el-Gendy, M. A., Chem. Pharm. Bull., 46, 1486-1487 (1998).
10. Hasegawa, H., Uchiyama, M., Planta Med., 64, 696-700 (1998).
11. Kim, D. H., Hong, S. W., Kim, B. T., Bae, E. A., Park, H. Y., Han, M., Arch. Pharm. Res., 23, 172-177 (2000).
12. Nakazawa, T., Yasuda, T., Ohsawa, K., J. Pharm. Pharmacol. in press
13. Kawashima K., Araki H., Aihara H., Jap. J. Pharmacol., 40, 199-204 (1986).
14. Joca, S. R. L., Skalisz, L. L., Beijamini, V., Vital, M. A., Andreatini, R., Eur. Neuropsychopharmacol., 10, 223-228 (2000).
15. Nakazawa, T., Yasuda, T., Ueda, J., Ohsawa, K., Biol. Pharm. Bull., 26, 474-480 (2003).
16. Watanabe, K., Watanabe, H., Goto, Y., Yamaguchi, M., Yamamoto, M., Hagino, K., Planta Med., 49, 103-108 (1983).
17. Duncan, G. E., Breese G. R., Criswell, H., Stumpf, W. E., Mueller, R. A., Covey, J. B., J. Pharmacol. Exp. Ther., 238, 758-762 (1986).
18. Connor, T. J., Kelliher, P., Harkin, A., Kelly, J. P., Leonard, B. E., Eur. J. Pharmacol., 397, 125-1133 (1999).
19. Vaugeois, J. M., Pouhe, D., Zuccaro, F., Costentin, J., Pharmacol. Biochem. Behav., 54, 235-239 (1996).
20. Tanaka, M., Kohno, Y., Nakagawa, R., Ida, Y., Takeda, S., Nagasaki, N., Pharmacol. Biochem. Behav., 16, 315-319 (1982).
21. Johnston, C. A., Spinedi, E. J., Negro-Vilar, A., Neuroendocrinology, 41, 83-88 (1985).
22. Barros, H. M. T., Leite, J. R., Psychopharmacology., 92, 340-342 (1987).
23. Sluzewska, A., Eur. Neuropsychopharmacol., 1, 404 (1991).
24. Hall, L. M., Anderson, G. M., Cohen, D. J., Life Sci., 57, 791-801 (1995).
25. Misu, Y., Goshima, Y., Ueda, H., Kubo, T., J. Pharmacol. Exp. Thera., 235, 771-777 (1985).
26. Rossetti, Z. L., Pani, L., Portas, C., Gessa, G., Eur. J. Pharmacol., 163, 393-395 (1989).
27. Ai, J., Wang, X., Nielsen, M., Pharmacology, 63, 34-41 (2001).
28. Nakagawa, Y., Ishima, T., Ishibashi, Y., Yoshii, T., Takashima, T., Brain Res., 709, 215-220 (1996).